Göttingen, Germany

Klaus-Armin Nave


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Goettingen, DE (2008 - 2016)
  • Göttingen, DE (2009 - 2021)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Klaus-Armin Nave: Innovator in Charcot-Marie-Tooth Disease Treatment

Introduction

Klaus-Armin Nave is a prominent inventor based in Göttingen, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of Charcot-Marie-Tooth Disease type 1A (CMT1A). With a total of 7 patents to his name, Nave's work has the potential to impact many lives.

Latest Patents

Nave's latest patents focus on innovative methods for treating, preventing, or delaying the onset of CMT1A. His inventions involve administering a combination of baclofen, sorbitol, and naltrexone, or a pharmaceutically acceptable salt thereof, to subjects in need. This approach aims to provide early treatment options for individuals affected by this debilitating condition.

Career Highlights

Throughout his career, Klaus-Armin Nave has worked with notable companies such as Sygnis Bioscience GmbH & Co. KG and Pharnext. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Nave has collaborated with esteemed colleagues, including Daniel Cohen and Ilya Chumakov. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.

Conclusion

Klaus-Armin Nave's contributions to the treatment of Charcot-Marie-Tooth Disease type 1A highlight his dedication to innovation in medicine. His patents and collaborations reflect a commitment to improving the lives of those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…